Supplementary Figure S4 from Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial | Synapse
August 1, 2024Open Access
Supplementary Figure S4 from Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure S4. Time to PSA progression (TTP).